Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · IEX Real-Time Price · USD
1.630
+0.090 (5.84%)
At close: May 2, 2024, 4:00 PM
1.610
-0.020 (-1.23%)
After-hours: May 2, 2024, 4:53 PM EDT
Rockwell Medical Revenue
In the year 2023, Rockwell Medical had annual revenue of $83.61M with 14.84% growth. Revenue in the quarter ending December 31, 2023 was $22.09M with 14.39% year-over-year growth.
Revenue (ttm)
$83.61M
Revenue Growth
+14.84%
P/S Ratio
0.57
Revenue / Employee
$352,793
Employees
237
Market Cap
47.86M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 83.61M | 10.80M | 14.84% |
Dec 31, 2022 | 72.81M | 10.88M | 17.57% |
Dec 31, 2021 | 61.93M | -266.00K | -0.43% |
Dec 31, 2020 | 62.20M | 894.00K | 1.46% |
Dec 31, 2019 | 61.30M | -2.09M | -3.29% |
Dec 31, 2018 | 63.39M | 6.09M | 10.63% |
Dec 31, 2017 | 57.30M | 4.02M | 7.54% |
Dec 31, 2016 | 53.28M | -2.07M | -3.73% |
Dec 31, 2015 | 55.35M | 1.16M | 2.14% |
Dec 31, 2014 | 54.19M | 1.81M | 3.45% |
Dec 31, 2013 | 52.38M | 2.54M | 5.09% |
Dec 31, 2012 | 49.84M | 876.16K | 1.79% |
Dec 31, 2011 | 48.97M | -10.59M | -17.78% |
Dec 31, 2010 | 59.55M | 4.83M | 8.82% |
Dec 31, 2009 | 54.73M | 3.06M | 5.93% |
Dec 31, 2008 | 51.67M | 8.62M | 20.03% |
Dec 31, 2007 | 43.05M | 14.41M | 50.30% |
Dec 31, 2006 | 28.64M | 943.90K | 3.41% |
Dec 31, 2005 | 27.69M | 9.75M | 54.33% |
Dec 31, 2004 | 17.94M | 2.97M | 19.87% |
Dec 31, 2003 | 14.97M | 3.47M | 30.22% |
Dec 31, 2002 | 11.50M | 2.48M | 27.51% |
Dec 31, 2001 | 9.02M | 1.56M | 20.90% |
Dec 31, 2000 | 7.46M | 768.09K | 11.48% |
Dec 31, 1999 | 6.69M | 1.42M | 26.86% |
Dec 31, 1998 | 5.27M | 1.95M | 58.87% |
Dec 31, 1997 | 3.32M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cytosorbents | 36.35M |
Cara Therapeutics | 20.97M |
DarioHealth | 20.35M |
Bolt Biotherapeutics | 7.88M |
Cyclo Therapeutics | 1.08M |
RMTI News
- 15 days ago - Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States - Business Wire
- 16 days ago - Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024 - Business Wire
- 4 weeks ago - Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda - Business Wire
- 5 weeks ago - Rockwell Medical Named 'Great Place to Work' for Second Year in a Row - Business Wire
- 6 weeks ago - Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023 - Business Wire
- 3 months ago - Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024 - Business Wire
- 4 months ago - Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund - Business Wire
- 6 months ago - Rockwell Medical Announces Third Quarter 2023 Results - Business Wire